Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,012 across all filing types
Latest filing 2022-04-06 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
2021年年度报告提示性公告
Report Publication Announcement Classification · 100% confidence The document is very short (342 characters) and is titled as a "2021 年年度报告提示性公告" which translates to "2021 Annual Report Reminder Announcement." It states that the full 2021 Annual Report and its summary have been disclosed on the official disclosure website and advises investors to review it. There is no actual financial data or report content included, only a notice about the report's availability. According to the MENU VS MEAL RULE, this is an announcement about the report publication, not the report itself. Therefore, the correct classification is Report Publication Announcement (RPA).
2022-04-06 Chinese
2021年度独立董事述职报告（郑健钊）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2021 by an independent director of the company. It details the director's attendance at board meetings, opinions on various company matters, committee work, on-site inspections, investor protection efforts, training, and other work related to governance and oversight. It does not contain financial statements or audit results, nor is it an announcement of voting results or a regulatory filing. The content focuses on board/management activities and governance oversight by an independent director. Therefore, it fits best under Board/Management Information (MANG). The document length is 3670 characters, which is relatively short but contains substantive content about board activities rather than just an announcement or certification, so it is not RNS or RPA.
2022-04-06 Chinese
关于康芝药业股份有限公司非经营性资金占用及其他关联资金往来情况
Audit Report / Information Classification · 95% confidence The document is titled as a "专项审核报告" which translates to a "special audit report" related to non-operating fund occupation and other related party fund transactions for the year ended December 31, 2021. It references auditing standards and provides an auditor's opinion on a specific summary table related to the company's financials. The document is not a full annual report but a standalone audit report focusing on a particular aspect of the company's financials. It is issued by a registered accounting firm and includes audit procedures and conclusions. The document length is short (971 characters) and contains an audit opinion, not a full financial report or announcement of a report. Therefore, it fits the category of Audit Report / Information (AR). FY 2021
2022-04-06 Chinese
关于公司2021年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the company's 2021 profit distribution plan, including the board of directors, supervisory board, and independent directors' opinions. It states that the profit distribution proposal will be submitted to the 2021 annual shareholders' meeting for approval. The document does not contain full financial statements or detailed financial performance data but focuses on the dividend distribution plan and related approvals. The document length is short (1381 characters) and is an announcement of a profit distribution plan rather than a full annual report or earnings release. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), as it announces the dividend distribution plan and related shareholder meeting submission.
2022-04-06 Chinese
公司2021年度财务决算报告
Annual Report Classification · 95% confidence The document is titled '2021 年度财务决算报告' which translates to '2021 Annual Financial Settlement Report'. It includes detailed financial statements such as the balance sheet, income statement, cash flow statement, and notes to the financial statements for the fiscal year ending December 31, 2021. It also mentions an audit report issued by an accounting firm with an unqualified opinion, confirming the financial statements fairly present the company's financial position and results. The document contains comprehensive financial data and analysis for the full fiscal year 2021, including revenue, profit, assets, liabilities, and other key financial metrics. The length is 2560 characters, which is sufficient for a detailed financial report rather than a brief announcement. Therefore, this document is a full Annual Report (10-K equivalent) rather than just an announcement or a certification. Hence, the correct classification is Annual Report (10-K). FY 2021
2022-04-06 Chinese
2021年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2021 Annual Report Summary" of 康芝药业股份有限公司, indicating it is a summary of the full annual report. It contains detailed company information, business overview, financial data for the year 2021, including key financial metrics, shareholder information, and significant corporate events during the year. The presence of audited financial data and comprehensive business descriptions aligns with the characteristics of an Annual Report. The document length (9847 characters) and content depth confirm it is the report itself, not merely an announcement or a certification. Therefore, the appropriate classification is Annual Report (10-K). FY 2021
2022-04-06 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.